About Us

Our Conference

The Boston Investment Conference gathers the brightest minds in the investment community together for a full day of insights, ideas and networking. Each year, conference proceeds benefit a new research initiative at Boston Children’s Hospital, as well as unique collaborations between Boston Children’s and the Broad Institute.


Our Impact

About 175 million children worldwide suffer from a rare disease—conditions that will kill 30% of them before age 5. But while in aggregate there are millions of children affected, each individual disease is extremely rare, stretching scientific resources thin and slowing searches for cures. This year the Boston Investment Conference will support the work of Timothy Yu, MD, PhD, who believes he has found a way to treat many of these children: building a system to deliver tailored genetic treatments using synthetic strands of genetic material called antisense oligonucleotides (ASOs). Dr. Yu’s breakthrough uses an ASO to block the effects of a mutated gene that is causing the disease.

With the support of the Boston Investment Conference, Dr. Yu will take this proof of principle forward and replicate this project for dozens of other children affected by rare diseases treatable by ASO therapy. His hope is that the trials will be so successful that other institutions will be inspired to follow our lead and reach thousands of more children around the world.


Boston Children's Hospital

Boston Children’s Hospital has been quietly changing the future of health for every child, here and around the world, since 1869. Named the number one hospital for care in the country, we are also the largest research center for pediatric medicine anywhere.

We have a legacy of medical breakthroughs; many leading to treatments for adults. Discoveries include the first measles vaccine, the first remission of leukemia, and the first solid organ transplant. We have been home to two Nobel Laureates, eight Lasker Award (America’s Nobel) winners, and four MacArthur “Genius Grant” Fellows. Boston Children’s receives more NIH grants than any other pediatric institution.


Speakers

Check back for additional speaker announcements.
For a full list of our previous speakers, click here.

Jason Adler

Jason Adler

Gotham Green Partners

Gavin Baker

Gavin Baker

Atreides Management

Will Danoff

Will Danoff

Fidelity Contrafund​

Josh Gold

Josh Gold

Three Bays Capital

David Gross-Loh

David Gross-Loh

Bain Capital

Seth Klarman

Seth Klarman

The Baupost Group, LLC

Philippe Laffont

Philippe Laffont

Coatue Management

James Morrow

James Morrow

Callodine Capital

Jason Robbins

Jason Robins

DraftKings

Alex Sacerdote

Alex Sacerdote

Whale Rock Capital Management

Niraj Shah

Niraj Shah

Wayfair

Brendan Swords

Brendan Swords

Wellington Management

Maria Zuber

Maria Zuber

Massachusetts Institute of Technology

Our 2018 Sponsors

Abrams Capital

IPO Sponsor

The Baupost Group

IPO Sponsor

FIdelity Investments

IPO Sponsor

J.P Morgan

Bull Market Sponsor

Whale Rock Capital Management LLC

Bull Market Sponsor

Berkshire Partners

Capital Gains Sponsor

Camber Capital

Capital Gains Sponsor

Sanford C. Bernstein Co.

Dividend Sponsor

Dockyard Capital Management

Dividend Sponsor

HarbourVest

Dividend Sponsor

Providence Equity

Dividend Sponsor

Taconic Capital

Dividend Sponsor

Wells Fargo Securities

Dividend Sponsor